🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, asserting the corporations withheld safety concerns that the medication presented to children's brain development.

This legal action arrives four weeks after President Donald Trump advocated an unproven link between using acetaminophen - also known as acetaminophen - while pregnant and autism in young ones.

The attorney general is suing J&J, which once produced the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which currently produces it.

In a declaration, he stated they "misled consumers by gaining financially from pain and promoting medication regardless of the potential hazards."

The manufacturer states there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These corporations misled for generations, deliberately risking millions to increase profits," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its website, the company also said it had "continuously evaluated the pertinent research and there is lacking reliable evidence that demonstrates a established connection between consuming paracetamol and autism spectrum disorder."

Associations representing doctors and healthcare providers share this view.

The leading OB-GYN organization has said paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can present serious health risks if left untreated.

"In more than two decades of research on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the usage of paracetamol in any stage of pregnancy results in neurological conditions in young ones," the group said.

The lawsuit references recent announcements from the previous government in arguing the medication is reportedly hazardous.

Last month, Trump generated worry from health experts when he advised women during pregnancy to "fight like hell" not to use acetaminophen when ill.

Federal regulators then published an announcement that medical professionals should think about restricting the use of Tylenol, while also mentioning that "a proven link" between the medication and autism in young ones has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in spring to undertake "a massive testing and research effort" that would establish the origin of autism in a short period.

But experts warned that discovering a unique factor of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and disability that influences how persons experience and relate to the world, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is campaigning for the Senate - claims Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

This legal action attempts to require the firms "remove any commercial messaging" that states Tylenol is reliable for expectant mothers.

The Texas lawsuit mirrors the complaints of a assembly of mothers and fathers of minors with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in 2022.

The court threw out the legal action, declaring research from the plaintiffs' authorities was lacking definitive proof.